107 related articles for article (PubMed ID: 35575434)
1. Editorial for "A Deep Learning Model Based on MRI and Clinical Factors Facilitates Noninvasive Prediction of KRAS Mutation in Rectal Cancer".
Fernandes MC; Horvat N
J Magn Reson Imaging; 2022 Dec; 56(6):1669-1670. PubMed ID: 35575434
[No Abstract] [Full Text] [Related]
2. A Deep Learning Model Based on MRI and Clinical Factors Facilitates Noninvasive Evaluation of KRAS Mutation in Rectal Cancer.
Liu H; Yin H; Li J; Dong X; Zheng H; Zhang T; Yin Q; Zhang Z; Lu M; Zhang H; Wang D
J Magn Reson Imaging; 2022 Dec; 56(6):1659-1668. PubMed ID: 35587946
[TBL] [Abstract][Full Text] [Related]
3. Prediction of KRAS Mutation in Rectal Cancer Using MRI.
Shin YR; Kim KA; Im S; Hwang SS; Kim K
Anticancer Res; 2016 Sep; 36(9):4799-804. PubMed ID: 27630331
[TBL] [Abstract][Full Text] [Related]
4. Radiogenomic and Deep Learning Network Approaches to Predict
Jang BS; Song C; Kang SB; Kim JS
Anticancer Res; 2021 Aug; 41(8):3969-3976. PubMed ID: 34281860
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of MRI Radiomics for Predicting KRAS Mutation in Rectal Cancer.
Guo XF; Yang WQ; Yang Q; Yuan ZL; Liu YL; Niu XH; Xu HB
Curr Med Sci; 2020 Dec; 40(6):1156-1160. PubMed ID: 33428144
[TBL] [Abstract][Full Text] [Related]
6. Could IVIM and ADC help in predicting the KRAS status in patients with rectal cancer?
Xu Y; Xu Q; Sun H; Liu T; Shi K; Wang W
Eur Radiol; 2018 Jul; 28(7):3059-3065. PubMed ID: 29450716
[TBL] [Abstract][Full Text] [Related]
7. Characterizing MRI features of rectal cancers with different KRAS status.
Xu Y; Xu Q; Ma Y; Duan J; Zhang H; Liu T; Li L; Sun H; Shi K; Xie S; Wang W
BMC Cancer; 2019 Nov; 19(1):1111. PubMed ID: 31727020
[TBL] [Abstract][Full Text] [Related]
8. [Comparative Evaluation of the Value of Quantitative Parameters of Dual-energy CT and MRI for KRAS Mutation in Rectal Cancer].
Lin XQ; Han T; Jing MY; Deng LN; Zhang B; Zhou JL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Aug; 44(4):606-613. PubMed ID: 36065693
[TBL] [Abstract][Full Text] [Related]
9. Magnetic Resonance-Based Texture Analysis Differentiating KRAS Mutation Status in Rectal Cancer.
Oh JE; Kim MJ; Lee J; Hur BY; Kim B; Kim DY; Baek JY; Chang HJ; Park SC; Oh JH; Cho SA; Sohn DK
Cancer Res Treat; 2020 Jan; 52(1):51-59. PubMed ID: 31096736
[TBL] [Abstract][Full Text] [Related]
10. Diffusion kurtosis imaging-derived histogram metrics for prediction of KRAS mutation in rectal adenocarcinoma: Preliminary findings.
Cui Y; Cui X; Yang X; Zhuo Z; Du X; Xin L; Yang Z; Cheng X
J Magn Reson Imaging; 2019 Sep; 50(3):930-939. PubMed ID: 30637861
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive KRAS mutation estimation in colorectal cancer using a deep learning method based on CT imaging.
He K; Liu X; Li M; Li X; Yang H; Zhang H
BMC Med Imaging; 2020 Jun; 20(1):59. PubMed ID: 32487083
[TBL] [Abstract][Full Text] [Related]
12. Role of KRAS mutation as predictor of pathologic response after neoadjuvant chemoradiation therapy for rectal cancer.
Martellucci J; Alemanno G; Castiglione F; Bergamini C; Valeri A
Updates Surg; 2015 Mar; 67(1):47-53. PubMed ID: 25702261
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of MRI-based deep learning models for prediction of microsatellite instability in rectal cancer.
Zhang W; Yin H; Huang Z; Zhao J; Zheng H; He D; Li M; Tan W; Tian S; Song B
Cancer Med; 2021 Jun; 10(12):4164-4173. PubMed ID: 33963688
[TBL] [Abstract][Full Text] [Related]
14. KRAS Mutant Status, p16 and β-catenin Expression May Predict Local Recurrence in Patients Who Underwent Transanal Endoscopic Microsurgery (TEMS) for Stage I Rectal Cancer.
Sideris M; Moorhead J; Diaz-Cano S; Bjarnason I; Haji A; Papagrigoriadis S
Anticancer Res; 2016 Oct; 36(10):5315-5324. PubMed ID: 27798894
[TBL] [Abstract][Full Text] [Related]
15. Histogram Analysis of Perfusion Parameters from Dynamic Contrast-Enhanced MR Imaging with Tumor Characteristics and Therapeutic Response in Locally Advanced Rectal Cancer.
Yeo DM; Oh SN; Choi MH; Lee SH; Lee MA; Jung SE
Biomed Res Int; 2018; 2018():3724393. PubMed ID: 30186857
[TBL] [Abstract][Full Text] [Related]
16. Analysis of KRAS, NRAS, BRAF, PIK3CA and TP53 mutations in a large prospective series of locally advanced rectal cancer patients.
Sclafani F; Wilson SH; Cunningham D; Gonzalez De Castro D; Kalaitzaki E; Begum R; Wotherspoon A; Capdevila J; Glimelius B; Roselló S; Thomas J; Tait D; Brown G; Oates J; Chau I
Int J Cancer; 2020 Jan; 146(1):94-102. PubMed ID: 31199501
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of KRAS Mutation Status in Rectal Cancer.
Jo P; König A; Schirmer M; Kitz J; Conradi LC; Azizian A; Bernhardt M; Wolff HA; Grade M; Ghadimi M; Ströbel P; Schildhaus HU; Gaedcke J
PLoS One; 2016; 11(4):e0153278. PubMed ID: 27064574
[TBL] [Abstract][Full Text] [Related]
18. Oncogene mutation profile predicts tumor regression and survival in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and radical surgery.
Peng J; Lin J; Qiu M; Zhao Y; Deng Y; Shao J; Ding P; Zhang H; Wan D; Lu Z; Pan Z
Tumour Biol; 2017 Jul; 39(7):1010428317709638. PubMed ID: 28671043
[TBL] [Abstract][Full Text] [Related]
19. KRAS mutation status concordance between the primary tumor and the corresponding metastasis in patients with rectal cancer.
Jo P; Bernhardt M; Nietert M; König A; Azizian A; Schirmer MA; Grade M; Kitz J; Reuter-Jessen K; Ghadimi M; Ströbel P; Schildhaus HU; Gaedcke J
PLoS One; 2020; 15(10):e0239806. PubMed ID: 33002027
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of KRAS mutation in locally advanced rectal cancer.
Asawa P; Bakalov V; Kancharla P; Abel S; Chahine Z; Monga DK; Kirichenko AV; Wegner RE
Int J Colorectal Dis; 2022 May; 37(5):1199-1207. PubMed ID: 35484252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]